Stem cell bone graft shows promise for back pain relief
NCT ID NCT00941980
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested Osteocel Plus, a bone graft material that contains stem cells, in 28 adults with degenerative disc disease who needed spinal fusion surgery. The goal was to see if it helps the spine bones fuse together as well as standard bone grafts. Researchers measured fusion rates and complications over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Osteocel Plus (a stem cell bone graft)
- What this could lead to
- If successful, this could offer a safer alternative to traditional bone grafts for spinal fusion, reducing the need for a second surgical site.
- What could go wrong
- This is a small, early study with only 28 participants, so results may not apply to everyone. There is also a risk of complications like infection or non-union of the spine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Spine, Orthopaedic Rehabilitation Center, Lovelace Medical Center
Albuquerque, New Mexico, 87102, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 3D-Printed spinal cages could revolutionize back surgery
- Bone scan may help avoid unnecessary back surgery
- 5,000+ patients enrolled in spine device safety study
- Scientists scan brains to unlock cannabis pain relief secrets
- New study tests drug-free pain relief after back surgery to cut opioid use
- Could a disc injection replace surgery for back pain?